Journal of obstetrics and gynaecology of India
Nov 30, 2023
ChatGPT, the new bustle in the field of technology, is attracting millions of users worldwide with its impressive skills to perform multiple tasks in a way that mimics human conversation. We conducted this study at two levels with direct and case-bas...
Journal of obstetrics and gynaecology of India
Jun 26, 2021
OBJECTIVES: This prospective clinical trial was conducted to assess serum bile acids (BA) levels in women with intrahepatic cholestasis of pregnancy (ICP) compared to both pregnant and non-pregnant controls; and evaluate perinatal outcome in relation...
Journal of obstetrics and gynaecology of India
Dec 6, 2018
PURPOSE: Vitamin D deficiency has been proposed to be a risk factor in the pathogenesis of uterine fibroid in few recently published studies conducted in Europe and Africa. Nevertheless, no study has ever addressed similar query in Indian women where...
Journal of obstetrics and gynaecology of India
Feb 21, 2018
INTRODUCTION: Recurrent pregnancy loss (RPL) is defined as three or more spontaneous pregnancy losses before the 20th week of gestation or fetal weight of < 500 gm from the last menstrual period. Vascular endothelial growth factor (VEGF) is essential...
Journal of obstetrics and gynaecology of India
Nov 16, 2017
BACKGROUND: Various medical methods for second-trimester medical termination of pregnancy (MTP) exist. Misoprostol alone has been used with myriad variations in route and dosage. Comparison between oral and vaginal routes of misoprostol forms the bas...
Journal of obstetrics and gynaecology of India
Jul 7, 2016
OBJECTIVES: The aim of the study was to identify the risk factors predisposing to morbidly adherent placenta and to study the different modes of management and the obstetric and neonatal outcome of these patients.
Journal of obstetrics and gynaecology of India
Jan 31, 2015
BACKGROUND: Ectopic pregnancy (EP) is the commonest cause of maternal mortality-related death in the first trimester. Methotrexate (MTX) remains the first-line treatment in optimally selected patients.